Skip to main content
Top
Published in: Immunity & Ageing 1/2013

Open Access 01-12-2013 | Review

Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes

Authors: Gaetano Santulli, Guido Iaccarino

Published in: Immunity & Ageing | Issue 1/2013

Login to get access

Abstract

G protein-coupled receptors (GPCRs) play a key role in cellular communication, allowing human cells to sense external cues or to talk each other through hormones or neurotransmitters. Research in this field has been recently awarded with the Nobel Prize in chemistry to Robert J. Lefkowitz and Brian K. Kobilka, for their pioneering work on beta adrenergic receptors (βARs), a prototype GPCR. Such receptors, and β2AR in particular, which is extensively distributed throughout the body, are involved in a number of pathophysiological processes. Moreover, a large amount of studies has demonstrated their participation in ageing process. Reciprocally, age-related changes in regulation of receptor responses have been observed in numerous tissues and include modifications of βAR responses. Impaired sympathetic nervous system function has been indeed evoked as at least a partial explanation for several modifications that occur with ageing. This article represents an updated presentation of the current knowledge in the field, summarizing in a systematic way the major findings of research on ageing in several organs and tissues (crime scenes) expressing βARs: heart, vessels, skeletal muscle, respiratory system, brain, immune system, pancreatic islets, liver, kidney and bone.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ: Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science. 1988, 240 (4857): 1310-1316. 10.1126/science.2836950.PubMedCrossRef Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ: Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science. 1988, 240 (4857): 1310-1316. 10.1126/science.2836950.PubMedCrossRef
3.
go back to reference Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ: cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A. 1987, 84 (1): 46-50. 10.1073/pnas.84.1.46.PubMedCentralPubMedCrossRef Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ: cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A. 1987, 84 (1): 46-50. 10.1073/pnas.84.1.46.PubMedCentralPubMedCrossRef
4.
5.
go back to reference Kenakin T, Agnati LF, Caron M, Fredholm B, Guidoli D, Kobilka B, Lefkowitz RW, Lohse M, Woods A, Fuxe K: International Workshop at the Nobel Forum, Karolinska Institutet on G protein-coupled receptors: finding the words to describe monomers, oligomers, and their molecular mechanisms and defining their meaning. Can a consensus be reached?. J Recept Signal Transduct Res. 2010, 30 (5): 284-286. 10.3109/10799893.2010.512438.PubMedCrossRef Kenakin T, Agnati LF, Caron M, Fredholm B, Guidoli D, Kobilka B, Lefkowitz RW, Lohse M, Woods A, Fuxe K: International Workshop at the Nobel Forum, Karolinska Institutet on G protein-coupled receptors: finding the words to describe monomers, oligomers, and their molecular mechanisms and defining their meaning. Can a consensus be reached?. J Recept Signal Transduct Res. 2010, 30 (5): 284-286. 10.3109/10799893.2010.512438.PubMedCrossRef
6.
go back to reference Clark RB: Profile of Brian K Kobilka and Robert J Lefkowitz, 2012 Nobel Laureates in Chemistry. Proc Natl Acad Sci USA. 2013, (Epub ahead of print) Clark RB: Profile of Brian K Kobilka and Robert J Lefkowitz, 2012 Nobel Laureates in Chemistry. Proc Natl Acad Sci USA. 2013, (Epub ahead of print)
7.
go back to reference Roth BL, Marshall FH: NOBEL 2012 Chemistry: Studies of a ubiquitous receptor family. Nature. 2012, 492 (7427): 57-10.1038/492057a.PubMedCrossRef Roth BL, Marshall FH: NOBEL 2012 Chemistry: Studies of a ubiquitous receptor family. Nature. 2012, 492 (7427): 57-10.1038/492057a.PubMedCrossRef
8.
go back to reference Liggett SB: Update on current concepts of the molecular basis of beta2-adrenergic receptor signaling. J Allergy Clin Immunol. 2002, 110 (6 Suppl): S223-S227.PubMedCrossRef Liggett SB: Update on current concepts of the molecular basis of beta2-adrenergic receptor signaling. J Allergy Clin Immunol. 2002, 110 (6 Suppl): S223-S227.PubMedCrossRef
9.
go back to reference Gauthier C, Rozec B, Manoury B, Balligand JL: Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies. Curr Heart Fail Rep. 2011, 8 (3): 184-192. 10.1007/s11897-011-0064-6.PubMedCrossRef Gauthier C, Rozec B, Manoury B, Balligand JL: Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies. Curr Heart Fail Rep. 2011, 8 (3): 184-192. 10.1007/s11897-011-0064-6.PubMedCrossRef
10.
go back to reference Collins S, Cao W, Robidoux J: Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol Endocrinol. 2004, 18 (9): 2123-2131. 10.1210/me.2004-0193.PubMedCrossRef Collins S, Cao W, Robidoux J: Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol Endocrinol. 2004, 18 (9): 2123-2131. 10.1210/me.2004-0193.PubMedCrossRef
11.
go back to reference Reiter E, Ahn S, Shukla AK, Lefkowitz RJ: Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol. 2012, 52: 179-197. 10.1146/annurev.pharmtox.010909.105800.PubMedCentralPubMedCrossRef Reiter E, Ahn S, Shukla AK, Lefkowitz RJ: Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol. 2012, 52: 179-197. 10.1146/annurev.pharmtox.010909.105800.PubMedCentralPubMedCrossRef
12.
go back to reference Hara MR, Sachs BD, Caron MG, Lefkowitz RJ: Pharmacological blockade of a beta(2)AR-beta-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model. Cell cycle. 2013, 12 (2): 219-224. 10.4161/cc.23368.PubMedCentralPubMedCrossRef Hara MR, Sachs BD, Caron MG, Lefkowitz RJ: Pharmacological blockade of a beta(2)AR-beta-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model. Cell cycle. 2013, 12 (2): 219-224. 10.4161/cc.23368.PubMedCentralPubMedCrossRef
13.
go back to reference Daaka Y, Luttrell LM, Lefkowitz RJ: Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature. 1997, 390 (6655): 88-91. 10.1038/36362.PubMedCrossRef Daaka Y, Luttrell LM, Lefkowitz RJ: Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature. 1997, 390 (6655): 88-91. 10.1038/36362.PubMedCrossRef
14.
go back to reference Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Pineyro G: Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A. 2003, 100 (20): 11406-11411. 10.1073/pnas.1936664100.PubMedCentralPubMedCrossRef Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Pineyro G: Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A. 2003, 100 (20): 11406-11411. 10.1073/pnas.1936664100.PubMedCentralPubMedCrossRef
15.
go back to reference Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ: G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem. 1997, 272 (50): 31648-31656. 10.1074/jbc.272.50.31648.PubMedCrossRef Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ: G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem. 1997, 272 (50): 31648-31656. 10.1074/jbc.272.50.31648.PubMedCrossRef
16.
go back to reference Nygaard R, Zou Y, Dror RO, Mildorf TJ, Arlow DH, Manglik A, Pan AC, Liu CW, Fung JJ, Bokoch MP: The Dynamic Process of beta(2)-Adrenergic Receptor Activation. Cell. 2013, 152 (3): 532-542. 10.1016/j.cell.2013.01.008.PubMedCentralPubMedCrossRef Nygaard R, Zou Y, Dror RO, Mildorf TJ, Arlow DH, Manglik A, Pan AC, Liu CW, Fung JJ, Bokoch MP: The Dynamic Process of beta(2)-Adrenergic Receptor Activation. Cell. 2013, 152 (3): 532-542. 10.1016/j.cell.2013.01.008.PubMedCentralPubMedCrossRef
17.
go back to reference Houslay MD, Kolch W: Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol. 2000, 58 (4): 659-668.PubMed Houslay MD, Kolch W: Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol. 2000, 58 (4): 659-668.PubMed
18.
go back to reference Sun Y, Huang J, Xiang Y, Bastepe M, Juppner H, Kobilka BK, Zhang JJ, Huang XY: Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR. EMBO J. 2007, 26 (1): 53-64. 10.1038/sj.emboj.7601502.PubMedCentralPubMedCrossRef Sun Y, Huang J, Xiang Y, Bastepe M, Juppner H, Kobilka BK, Zhang JJ, Huang XY: Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR. EMBO J. 2007, 26 (1): 53-64. 10.1038/sj.emboj.7601502.PubMedCentralPubMedCrossRef
19.
go back to reference Hall RA, Premont RT, Chow CW, Blitzer JT, Pitcher JA, Claing A, Stoffel RH, Barak LS, Shenolikar S, Weinman EJ: The beta2-adrenergic receptor interacts with the Na+/H+−exchanger regulatory factor to control Na+/H+ exchange. Nature. 1998, 392 (6676): 626-630. 10.1038/33458.PubMedCrossRef Hall RA, Premont RT, Chow CW, Blitzer JT, Pitcher JA, Claing A, Stoffel RH, Barak LS, Shenolikar S, Weinman EJ: The beta2-adrenergic receptor interacts with the Na+/H+−exchanger regulatory factor to control Na+/H+ exchange. Nature. 1998, 392 (6676): 626-630. 10.1038/33458.PubMedCrossRef
20.
go back to reference Santulli G, Lombardi A, Sorriento D, Anastasio A, Del Giudice C, Formisano P, Beguinot F, Trimarco B, Miele C, Iaccarino G: Age-related impairment in insulin release: the essential role of beta(2)-adrenergic receptor. Diabetes. 2012, 61 (3): 692-701. 10.2337/db11-1027.PubMedCentralPubMedCrossRef Santulli G, Lombardi A, Sorriento D, Anastasio A, Del Giudice C, Formisano P, Beguinot F, Trimarco B, Miele C, Iaccarino G: Age-related impairment in insulin release: the essential role of beta(2)-adrenergic receptor. Diabetes. 2012, 61 (3): 692-701. 10.2337/db11-1027.PubMedCentralPubMedCrossRef
21.
go back to reference Weiss DR, Ahn S, Sassano MF, Kleist A, Zhu X, Strachan R, Roth BL, Lefkowitz RJ, Shoichet BK: Conformation guides molecular efficacy in docking screens of activated beta-2 adrenergic G protein coupled receptor. ACS Chem Biol. 2013, (Epub ahead of print) Weiss DR, Ahn S, Sassano MF, Kleist A, Zhu X, Strachan R, Roth BL, Lefkowitz RJ, Shoichet BK: Conformation guides molecular efficacy in docking screens of activated beta-2 adrenergic G protein coupled receptor. ACS Chem Biol. 2013, (Epub ahead of print)
22.
go back to reference Holliday R: Understanding ageing. Phil Trans Roy Soc Lond B Biol Sci. 1997, 352 (1363): 1793-1797. 10.1098/rstb.1997.0163.CrossRef Holliday R: Understanding ageing. Phil Trans Roy Soc Lond B Biol Sci. 1997, 352 (1363): 1793-1797. 10.1098/rstb.1997.0163.CrossRef
23.
go back to reference Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE ESY, Lamming DW: Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science. 2013, 339 (6124): 1216-1219. 10.1126/science.1231097.PubMedCentralPubMedCrossRef Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE ESY, Lamming DW: Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science. 2013, 339 (6124): 1216-1219. 10.1126/science.1231097.PubMedCentralPubMedCrossRef
24.
go back to reference Rymkiewicz PD, Heng YX, Vasudev A, Larbi A: The immune system in the aging human. Immunol Res. 2012, 53 (1–3): 235-250.PubMedCrossRef Rymkiewicz PD, Heng YX, Vasudev A, Larbi A: The immune system in the aging human. Immunol Res. 2012, 53 (1–3): 235-250.PubMedCrossRef
25.
go back to reference Holliday R, Rattan SI: Longevity mutants do not establish any "new science" of ageing. Biogerontology. 2010, 11 (4): 507-511. 10.1007/s10522-010-9288-1.PubMedCrossRef Holliday R, Rattan SI: Longevity mutants do not establish any "new science" of ageing. Biogerontology. 2010, 11 (4): 507-511. 10.1007/s10522-010-9288-1.PubMedCrossRef
26.
go back to reference Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, Towers AJ, Williams B, Lam CM, Xiao K: A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature. 2011, 477 (7364): 349-353. 10.1038/nature10368.PubMedCentralPubMedCrossRef Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, Towers AJ, Williams B, Lam CM, Xiao K: A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature. 2011, 477 (7364): 349-353. 10.1038/nature10368.PubMedCentralPubMedCrossRef
27.
go back to reference Raj K, Chanu SI, Sarkar S: Decoding Complexity of Aging. Cell Dev Biol. 2012, 1: e117-CrossRef Raj K, Chanu SI, Sarkar S: Decoding Complexity of Aging. Cell Dev Biol. 2012, 1: e117-CrossRef
28.
go back to reference Abete P, Testa G, Della-Morte D, Gargiulo G, Galizia G, de Santis D, Magliocca A, Basile C, Cacciatore F: Treatment for chronic heart failure in the elderly: current practice and problems. Hear Fail Rev. 2012,  -[Epub ahead of print] Abete P, Testa G, Della-Morte D, Gargiulo G, Galizia G, de Santis D, Magliocca A, Basile C, Cacciatore F: Treatment for chronic heart failure in the elderly: current practice and problems. Hear Fail Rev. 2012,  -[Epub ahead of print]
29.
go back to reference Greenblatt DJ, Koch-Weser J: Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program. Am Hear J. 1973, 86 (4): 478-484. 10.1016/0002-8703(73)90139-7.CrossRef Greenblatt DJ, Koch-Weser J: Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program. Am Hear J. 1973, 86 (4): 478-484. 10.1016/0002-8703(73)90139-7.CrossRef
30.
go back to reference Lakatta EG: Alterations in the cardiovascular system that occur in advanced age. Fed Proc. 1979, 38 (2): 163-167.PubMed Lakatta EG: Alterations in the cardiovascular system that occur in advanced age. Fed Proc. 1979, 38 (2): 163-167.PubMed
31.
go back to reference Xiao RP, Lakatta EG: Deterioration of beta-adrenergic modulation of cardiovascular function with aging. Ann N Y Acad Sci. 1992, 673: 293-310. 10.1111/j.1749-6632.1992.tb27465.x.PubMedCrossRef Xiao RP, Lakatta EG: Deterioration of beta-adrenergic modulation of cardiovascular function with aging. Ann N Y Acad Sci. 1992, 673: 293-310. 10.1111/j.1749-6632.1992.tb27465.x.PubMedCrossRef
32.
go back to reference Heinsimer JA, Lefkowitz RJ: The impact of aging on adrenergic receptor function: clinical and biochemical aspects. J Am Geriatr Soc. 1985, 33 (3): 184-188.PubMedCrossRef Heinsimer JA, Lefkowitz RJ: The impact of aging on adrenergic receptor function: clinical and biochemical aspects. J Am Geriatr Soc. 1985, 33 (3): 184-188.PubMedCrossRef
33.
go back to reference Arribas S, Marin J, Ponte A, Balfagon G, Salaices M: Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension. J Pharmacol Exp Ther. 1994, 270 (2): 520-527.PubMed Arribas S, Marin J, Ponte A, Balfagon G, Salaices M: Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension. J Pharmacol Exp Ther. 1994, 270 (2): 520-527.PubMed
34.
go back to reference Pan HY, Hoffman BB, Pershe RA, Blaschke TF: Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther. 1986, 239 (3): 802-807.PubMed Pan HY, Hoffman BB, Pershe RA, Blaschke TF: Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther. 1986, 239 (3): 802-807.PubMed
35.
go back to reference Ford GA, Hoffman BB, Vestal RE, Blaschke TF: Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man. Br J Clin Pharmacol. 1992, 33 (1): 83-87. 10.1111/j.1365-2125.1992.tb04004.x.PubMedCentralPubMedCrossRef Ford GA, Hoffman BB, Vestal RE, Blaschke TF: Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man. Br J Clin Pharmacol. 1992, 33 (1): 83-87. 10.1111/j.1365-2125.1992.tb04004.x.PubMedCentralPubMedCrossRef
36.
go back to reference van Brummelen P, Buhler FR, Kiowski W, Amann FW: Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci. 1981, 60 (5): 571-577.PubMedCrossRef van Brummelen P, Buhler FR, Kiowski W, Amann FW: Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci. 1981, 60 (5): 571-577.PubMedCrossRef
37.
go back to reference Ciccarelli M, Santulli G, Campanile A, Galasso G, Cervero P, Altobelli GG, Cimini V, Pastore L, Piscione F, Trimarco B: Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol. 2008, 153 (5): 936-946.PubMedCentralPubMedCrossRef Ciccarelli M, Santulli G, Campanile A, Galasso G, Cervero P, Altobelli GG, Cimini V, Pastore L, Piscione F, Trimarco B: Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol. 2008, 153 (5): 936-946.PubMedCentralPubMedCrossRef
38.
go back to reference Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B: CaMK4 Gene Deletion Induces Hypertension. J Am Heart Assoc. 2012, 1 (4): e001081-10.1161/JAHA.112.001081.PubMedCentralPubMedCrossRef Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B: CaMK4 Gene Deletion Induces Hypertension. J Am Heart Assoc. 2012, 1 (4): e001081-10.1161/JAHA.112.001081.PubMedCentralPubMedCrossRef
39.
go back to reference Rezaee M, Penta K, Quertermous T: Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha(v)beta(3). Am J Physiol Heart Circ Physiol. 2002, 282 (5): H1924-H1932.PubMedCrossRef Rezaee M, Penta K, Quertermous T: Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha(v)beta(3). Am J Physiol Heart Circ Physiol. 2002, 282 (5): H1924-H1932.PubMedCrossRef
40.
go back to reference Santulli G, Basilicata MF, De Simone M, Del Giudice C, Anastasio A, Sorriento D, Saviano M, Del Gatto A, Trimarco B, Pedone C: Evaluation of the anti-angiogenic properties of the new selective alphaVbeta3 integrin antagonist RGDechiHCit. J Transl Med. 2011, 9: 7-10.1186/1479-5876-9-7.PubMedCentralPubMedCrossRef Santulli G, Basilicata MF, De Simone M, Del Giudice C, Anastasio A, Sorriento D, Saviano M, Del Gatto A, Trimarco B, Pedone C: Evaluation of the anti-angiogenic properties of the new selective alphaVbeta3 integrin antagonist RGDechiHCit. J Transl Med. 2011, 9: 7-10.1186/1479-5876-9-7.PubMedCentralPubMedCrossRef
41.
go back to reference Georgescu A, Pluteanu F, Flonta ML, Badila E, Dorobantu M, Popov D: Nebivolol induces a hyperpolarizing effect on smooth muscle cells in the mouse renal artery by activation of beta-2-adrenoceptors. Pharmacology. 2008, 81 (2): 110-117. 10.1159/000110011.PubMedCrossRef Georgescu A, Pluteanu F, Flonta ML, Badila E, Dorobantu M, Popov D: Nebivolol induces a hyperpolarizing effect on smooth muscle cells in the mouse renal artery by activation of beta-2-adrenoceptors. Pharmacology. 2008, 81 (2): 110-117. 10.1159/000110011.PubMedCrossRef
42.
go back to reference Sorriento D, Santulli G, Del Giudice C, Anastasio A, Trimarco B, Iaccarino G: Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension. 2012, 60 (1): 129-136. 10.1161/HYPERTENSIONAHA.111.189605.PubMedCrossRef Sorriento D, Santulli G, Del Giudice C, Anastasio A, Trimarco B, Iaccarino G: Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension. 2012, 60 (1): 129-136. 10.1161/HYPERTENSIONAHA.111.189605.PubMedCrossRef
43.
go back to reference Puri R, Liew GY, Nicholls SJ, Nelson AJ, Leong DP, Carbone A, Copus B, Wong DT, Beltrame JF, Worthley SG: Coronary beta2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study. Eur Hear J. 2012, 33 (4): 495-504. 10.1093/eurheartj/ehr359.CrossRef Puri R, Liew GY, Nicholls SJ, Nelson AJ, Leong DP, Carbone A, Copus B, Wong DT, Beltrame JF, Worthley SG: Coronary beta2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study. Eur Hear J. 2012, 33 (4): 495-504. 10.1093/eurheartj/ehr359.CrossRef
44.
go back to reference Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG: Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res. 2005, 97 (11): 1182-1189. 10.1161/01.RES.0000191541.06788.bb.PubMedCrossRef Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG: Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res. 2005, 97 (11): 1182-1189. 10.1161/01.RES.0000191541.06788.bb.PubMedCrossRef
45.
go back to reference Ciccarelli M, Cipolletta E, Santulli G, Campanile A, Pumiglia K, Cervero P, Pastore L, Astone D, Trimarco B, Iaccarino G: Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. Cell Signal. 2007, 19 (9): 1949-1955. 10.1016/j.cellsig.2007.05.007.PubMedCrossRef Ciccarelli M, Cipolletta E, Santulli G, Campanile A, Pumiglia K, Cervero P, Pastore L, Astone D, Trimarco B, Iaccarino G: Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. Cell Signal. 2007, 19 (9): 1949-1955. 10.1016/j.cellsig.2007.05.007.PubMedCrossRef
46.
go back to reference Burger D, Kwart DG, Montezano AC, Read NC, Kennedy CR, Thompson CS, Touyz RM: Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence. J Am Heart Assoc. 2012, 1 (3): e001842-10.1161/JAHA.112.001842.PubMedCentralPubMedCrossRef Burger D, Kwart DG, Montezano AC, Read NC, Kennedy CR, Thompson CS, Touyz RM: Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence. J Am Heart Assoc. 2012, 1 (3): e001842-10.1161/JAHA.112.001842.PubMedCentralPubMedCrossRef
47.
go back to reference Schutzer WE, Mader SL: Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications. Ageing Res Rev. 2003, 2 (2): 169-190. 10.1016/S1568-1637(02)00063-6.PubMedCrossRef Schutzer WE, Mader SL: Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications. Ageing Res Rev. 2003, 2 (2): 169-190. 10.1016/S1568-1637(02)00063-6.PubMedCrossRef
48.
go back to reference Stessman J, Eliakim R, Cahan C, Ebstein RP: Deterioration of beta-receptor-adenylate cyclase function in elderly, hospitalized patients. J Gerontol. 1984, 39 (6): 667-672. 10.1093/geronj/39.6.667.PubMedCrossRef Stessman J, Eliakim R, Cahan C, Ebstein RP: Deterioration of beta-receptor-adenylate cyclase function in elderly, hospitalized patients. J Gerontol. 1984, 39 (6): 667-672. 10.1093/geronj/39.6.667.PubMedCrossRef
49.
go back to reference Scarpace PJ, Armbrecht HJ: Adenylate cyclase in senescence: catecholamine and parathyroid hormone pathways. Rev Clin Basic Pharmacol. 1987, 6 (2): 105-118. Scarpace PJ, Armbrecht HJ: Adenylate cyclase in senescence: catecholamine and parathyroid hormone pathways. Rev Clin Basic Pharmacol. 1987, 6 (2): 105-118.
50.
go back to reference Davinelli S, Willcox DC, Scapagnini G: Extending healthy ageing: nutrient sensitive pathway and centenarian population. Immun Ageing. 2012, 9: 9-10.1186/1742-4933-9-9.PubMedCentralPubMedCrossRef Davinelli S, Willcox DC, Scapagnini G: Extending healthy ageing: nutrient sensitive pathway and centenarian population. Immun Ageing. 2012, 9: 9-10.1186/1742-4933-9-9.PubMedCentralPubMedCrossRef
51.
go back to reference Wills M, Akbar A, Beswick M, Bosch JA, Caruso C, Colonna-Romano G, Dutta A, Franceschi C, Fulop T, Gkrania-Klotsas E: Report from the second cytomegalovirus and immunosenescence workshop. Immun Ageing. 2011, 8 (1): 10-10.1186/1742-4933-8-10.PubMedCentralPubMedCrossRef Wills M, Akbar A, Beswick M, Bosch JA, Caruso C, Colonna-Romano G, Dutta A, Franceschi C, Fulop T, Gkrania-Klotsas E: Report from the second cytomegalovirus and immunosenescence workshop. Immun Ageing. 2011, 8 (1): 10-10.1186/1742-4933-8-10.PubMedCentralPubMedCrossRef
52.
53.
go back to reference Vu TH, Stamler J, Liu K, McDermott MM, Lloyd-Jones DM, Pirzada A, Garside DB, Daviglus ML: Prospective relationship of low cardiovascular risk factor profile at younger ages to ankle-brachial index: 39-year follow-up-the chicago healthy aging study. J Am Heart Assoc. 2012, 1 (6): e001545-PubMedCentralPubMedCrossRef Vu TH, Stamler J, Liu K, McDermott MM, Lloyd-Jones DM, Pirzada A, Garside DB, Daviglus ML: Prospective relationship of low cardiovascular risk factor profile at younger ages to ankle-brachial index: 39-year follow-up-the chicago healthy aging study. J Am Heart Assoc. 2012, 1 (6): e001545-PubMedCentralPubMedCrossRef
54.
go back to reference Begum N, Shen W, Manganiello V: Role of PDE3A in regulation of cell cycle progression in mouse vascular smooth muscle cells and oocytes: implications in cardiovascular diseases and infertility. Curr Opin Pharmacol. 2011, 11 (6): 725-729. 10.1016/j.coph.2011.10.006.PubMedCentralPubMedCrossRef Begum N, Shen W, Manganiello V: Role of PDE3A in regulation of cell cycle progression in mouse vascular smooth muscle cells and oocytes: implications in cardiovascular diseases and infertility. Curr Opin Pharmacol. 2011, 11 (6): 725-729. 10.1016/j.coph.2011.10.006.PubMedCentralPubMedCrossRef
55.
go back to reference Santulli G, Trimarco B, Iaccarino G: GRK2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Pres Cardiovasc Prev. 2013,  -in press Santulli G, Trimarco B, Iaccarino G: GRK2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Pres Cardiovasc Prev. 2013,  -in press
56.
go back to reference Kang KB, Rajanayagam MA, van der Zypp A, Majewski H: A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas. N Schmied Arch Pharmacol. 2007, 375 (4): 273-281. 10.1007/s00210-007-0153-y.CrossRef Kang KB, Rajanayagam MA, van der Zypp A, Majewski H: A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas. N Schmied Arch Pharmacol. 2007, 375 (4): 273-281. 10.1007/s00210-007-0153-y.CrossRef
57.
go back to reference Trimarco B: Modern clinical management of arterial hypertension: fixed or free combination therapies? Foreword. High Blood Pres Cardiovasc Prev. 2011, 18 (Suppl 1): 1-2.CrossRef Trimarco B: Modern clinical management of arterial hypertension: fixed or free combination therapies? Foreword. High Blood Pres Cardiovasc Prev. 2011, 18 (Suppl 1): 1-2.CrossRef
58.
go back to reference Iaccarino G, Ciccarelli M, Sorriento D, Cipolletta E, Cerullo V, Iovino GL, Paudice A, Elia A, Santulli G, Campanile A: AKT participates in endothelial dysfunction in hypertension. Circulation. 2004, 109 (21): 2587-2593. 10.1161/01.CIR.0000129768.35536.FA.PubMedCrossRef Iaccarino G, Ciccarelli M, Sorriento D, Cipolletta E, Cerullo V, Iovino GL, Paudice A, Elia A, Santulli G, Campanile A: AKT participates in endothelial dysfunction in hypertension. Circulation. 2004, 109 (21): 2587-2593. 10.1161/01.CIR.0000129768.35536.FA.PubMedCrossRef
59.
go back to reference Montesanto A, Dato S, Bellizzi D, Rose G, Passarino G: Epidemiological, genetic and epigenetic aspects of the research on healthy ageing and longevity. Immun Ageing. 2012, 9 (1): 6-10.1186/1742-4933-9-6.PubMedCentralPubMedCrossRef Montesanto A, Dato S, Bellizzi D, Rose G, Passarino G: Epidemiological, genetic and epigenetic aspects of the research on healthy ageing and longevity. Immun Ageing. 2012, 9 (1): 6-10.1186/1742-4933-9-6.PubMedCentralPubMedCrossRef
60.
go back to reference Ziegler MG, Lake CR, Kopin IJ: Plasma noradrenaline increases with age. Nature. 1976, 261 (5558): 333-335. 10.1038/261333a0.PubMedCrossRef Ziegler MG, Lake CR, Kopin IJ: Plasma noradrenaline increases with age. Nature. 1976, 261 (5558): 333-335. 10.1038/261333a0.PubMedCrossRef
61.
go back to reference Gurdal H, Friedman E, Johnson MD: Beta-adrenoceptor-G alpha S coupling decreases with age in rat aorta. Mol Pharmacol. 1995, 47 (4): 772-778.PubMed Gurdal H, Friedman E, Johnson MD: Beta-adrenoceptor-G alpha S coupling decreases with age in rat aorta. Mol Pharmacol. 1995, 47 (4): 772-778.PubMed
62.
go back to reference Izzo R, Cipolletta E, Ciccarelli M, Campanile A, Santulli G, Palumbo G, Vasta A, Formisano S, Trimarco B, Iaccarino G: Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. Clin Transl Sci. 2008, 1 (3): 215-220. 10.1111/j.1752-8062.2008.00050.x.PubMedCrossRef Izzo R, Cipolletta E, Ciccarelli M, Campanile A, Santulli G, Palumbo G, Vasta A, Formisano S, Trimarco B, Iaccarino G: Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. Clin Transl Sci. 2008, 1 (3): 215-220. 10.1111/j.1752-8062.2008.00050.x.PubMedCrossRef
63.
go back to reference Santulli G, Campanile A, Spinelli L, Assante Di Panzillo E, Ciccarelli M, Trimarco B, Laccarino G: G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am J Cardiol. 2011, 107 (8): 1125-1130. 10.1016/j.amjcard.2010.12.006.PubMedCrossRef Santulli G, Campanile A, Spinelli L, Assante Di Panzillo E, Ciccarelli M, Trimarco B, Laccarino G: G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am J Cardiol. 2011, 107 (8): 1125-1130. 10.1016/j.amjcard.2010.12.006.PubMedCrossRef
64.
go back to reference Schutzer WE, Xue H, Reed J, Oyama T, Beard DR, Anderson S, Mader SL: Age-related beta-adrenergic receptor-mediated vasorelaxation is changed by altering G protein receptor kinase 2 expression. Vasc Pharmacol. 2011, 55 (5–6): 178-188.CrossRef Schutzer WE, Xue H, Reed J, Oyama T, Beard DR, Anderson S, Mader SL: Age-related beta-adrenergic receptor-mediated vasorelaxation is changed by altering G protein receptor kinase 2 expression. Vasc Pharmacol. 2011, 55 (5–6): 178-188.CrossRef
65.
go back to reference Borkowski KR, Gros R, Schneider H: Vascular beta-adrenoceptor-mediated responses in hypertension and ageing in rats. J Auton Pharmacol. 1992, 12 (6): 389-401. 10.1111/j.1474-8673.1992.tb00387.x.PubMedCrossRef Borkowski KR, Gros R, Schneider H: Vascular beta-adrenoceptor-mediated responses in hypertension and ageing in rats. J Auton Pharmacol. 1992, 12 (6): 389-401. 10.1111/j.1474-8673.1992.tb00387.x.PubMedCrossRef
66.
go back to reference Gros R, Benovic JL, Tan CM, Feldman RD: G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest. 1997, 99 (9): 2087-2093. 10.1172/JCI119381.PubMedCentralPubMedCrossRef Gros R, Benovic JL, Tan CM, Feldman RD: G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest. 1997, 99 (9): 2087-2093. 10.1172/JCI119381.PubMedCentralPubMedCrossRef
67.
go back to reference Xiao RP, Tomhave ED, Wang DJ, Ji X, Boluyt MO, Cheng H, Lakatta EG, Koch WJ: Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Investig. 1998, 101 (6): 1273-1282. 10.1172/JCI1335.PubMedCentralPubMedCrossRef Xiao RP, Tomhave ED, Wang DJ, Ji X, Boluyt MO, Cheng H, Lakatta EG, Koch WJ: Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Investig. 1998, 101 (6): 1273-1282. 10.1172/JCI1335.PubMedCentralPubMedCrossRef
68.
go back to reference Brandfonbrener M, Landowne M, Shock NW: Changes in cardiac output with age. Circulation. 1955, 12 (4): 557-566. 10.1161/01.CIR.12.4.557.PubMedCrossRef Brandfonbrener M, Landowne M, Shock NW: Changes in cardiac output with age. Circulation. 1955, 12 (4): 557-566. 10.1161/01.CIR.12.4.557.PubMedCrossRef
69.
go back to reference O'Connor SW, Scarpace PJ, Abrass IB: Age-associated decrease of adenylate cyclase activity in rat myocardium. Mech Ageing Dev. 1981, 16 (1): 91-95. 10.1016/0047-6374(81)90036-1.PubMedCrossRef O'Connor SW, Scarpace PJ, Abrass IB: Age-associated decrease of adenylate cyclase activity in rat myocardium. Mech Ageing Dev. 1981, 16 (1): 91-95. 10.1016/0047-6374(81)90036-1.PubMedCrossRef
70.
go back to reference Vestal RE, Wood AJ, Shand DG: Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979, 26 (2): 181-186.PubMedCrossRef Vestal RE, Wood AJ, Shand DG: Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979, 26 (2): 181-186.PubMedCrossRef
71.
go back to reference White M, Roden R, Minobe W, Khan MF, Larrabee P, Wollmering M, Port JD, Anderson F, Campbell D, Feldman AM: Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation. 1994, 90 (3): 1225-1238. 10.1161/01.CIR.90.3.1225.PubMedCrossRef White M, Roden R, Minobe W, Khan MF, Larrabee P, Wollmering M, Port JD, Anderson F, Campbell D, Feldman AM: Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation. 1994, 90 (3): 1225-1238. 10.1161/01.CIR.90.3.1225.PubMedCrossRef
72.
go back to reference Cerbai E, Guerra L, Varani K, Barbieri M, Borea PA, Mugelli A: Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: a combined patch-clamp and binding study. Br J Pharmacol. 1995, 116 (2): 1835-1842. 10.1111/j.1476-5381.1995.tb16671.x.PubMedCentralPubMedCrossRef Cerbai E, Guerra L, Varani K, Barbieri M, Borea PA, Mugelli A: Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: a combined patch-clamp and binding study. Br J Pharmacol. 1995, 116 (2): 1835-1842. 10.1111/j.1476-5381.1995.tb16671.x.PubMedCentralPubMedCrossRef
73.
go back to reference Ahmed A: Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure. Eur J Hear Fail. 2003, 5 (6): 709-715. 10.1016/S1388-9842(03)00058-8.CrossRef Ahmed A: Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure. Eur J Hear Fail. 2003, 5 (6): 709-715. 10.1016/S1388-9842(03)00058-8.CrossRef
74.
go back to reference Zaccolo M, Pozzan T: Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science. 2002, 295 (5560): 1711-1715. 10.1126/science.1069982.PubMedCrossRef Zaccolo M, Pozzan T: Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science. 2002, 295 (5560): 1711-1715. 10.1126/science.1069982.PubMedCrossRef
75.
go back to reference Perino A, Ghigo A, Ferrero E, Morello F, Santulli G, Baillie GS, Damilano F, Dunlop AJ, Pawson C, Walser R: Integrating Cardiac PIP(3) and cAMP Signaling through a PKA Anchoring Function of p110gamma. Mol Cell. 2011, 42 (1): 84-95. 10.1016/j.molcel.2011.01.030.PubMedCentralPubMedCrossRef Perino A, Ghigo A, Ferrero E, Morello F, Santulli G, Baillie GS, Damilano F, Dunlop AJ, Pawson C, Walser R: Integrating Cardiac PIP(3) and cAMP Signaling through a PKA Anchoring Function of p110gamma. Mol Cell. 2011, 42 (1): 84-95. 10.1016/j.molcel.2011.01.030.PubMedCentralPubMedCrossRef
76.
go back to reference Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, Lohse MJ, Korchev YE, Harding SE, Gorelik J: Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science. 2010, 327 (5973): 1653-1657. 10.1126/science.1185988.PubMedCrossRef Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, Lohse MJ, Korchev YE, Harding SE, Gorelik J: Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science. 2010, 327 (5973): 1653-1657. 10.1126/science.1185988.PubMedCrossRef
77.
go back to reference Lyon AR, Nikolaev VO, Miragoli M, Sikkel MB, Paur H, Benard L, Hulot JS, Kohlbrenner E, Hajjar RJ, Peters NS: Plasticity of surface structures and beta(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circulation Heart Failure. 2012, 5 (3): 357-365. 10.1161/CIRCHEARTFAILURE.111.964692.PubMedCrossRef Lyon AR, Nikolaev VO, Miragoli M, Sikkel MB, Paur H, Benard L, Hulot JS, Kohlbrenner E, Hajjar RJ, Peters NS: Plasticity of surface structures and beta(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circulation Heart Failure. 2012, 5 (3): 357-365. 10.1161/CIRCHEARTFAILURE.111.964692.PubMedCrossRef
78.
go back to reference Gao Z, Rasmussen TP, Li Y, Kutschke W, Koval OM, Wu Y, Wu Y, Hall DD, Joiner ML, Wu XQ: Genetic inhibition of na+−Ca2+ exchanger current disables fight or flight sinoatrial node activity without affecting resting heart rate. Circ Res. 2013, 112 (2): 309-317. 10.1161/CIRCRESAHA.111.300193.PubMedCentralPubMedCrossRef Gao Z, Rasmussen TP, Li Y, Kutschke W, Koval OM, Wu Y, Wu Y, Hall DD, Joiner ML, Wu XQ: Genetic inhibition of na+−Ca2+ exchanger current disables fight or flight sinoatrial node activity without affecting resting heart rate. Circ Res. 2013, 112 (2): 309-317. 10.1161/CIRCRESAHA.111.300193.PubMedCentralPubMedCrossRef
79.
go back to reference Liggett SB: Long-distance affair with adrenal GRK2 hangs up heart failure. Nat Med. 2007, 13 (3): 246-248. 10.1038/nm0307-246.PubMedCrossRef Liggett SB: Long-distance affair with adrenal GRK2 hangs up heart failure. Nat Med. 2007, 13 (3): 246-248. 10.1038/nm0307-246.PubMedCrossRef
80.
go back to reference Gilsbach R, Brede M, Beetz N, Moura E, Muthig V, Gerstner C, Barreto F, Neubauer S, Vieira-Coelho MA, Hein L: Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction. Cardiovasc Res. 2007, 75 (4): 728-737. 10.1016/j.cardiores.2007.05.017.PubMedCrossRef Gilsbach R, Brede M, Beetz N, Moura E, Muthig V, Gerstner C, Barreto F, Neubauer S, Vieira-Coelho MA, Hein L: Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction. Cardiovasc Res. 2007, 75 (4): 728-737. 10.1016/j.cardiores.2007.05.017.PubMedCrossRef
81.
go back to reference Cortez V, Santana M, Marques AP, Mota A, Rosmaninho-Salgado J, Cavadas C: Regulation of catecholamine release in human adrenal chromaffin cells by beta-adrenoceptors. Neurochem Int. 2012, 60 (4): 387-393. 10.1016/j.neuint.2011.12.018.PubMedCrossRef Cortez V, Santana M, Marques AP, Mota A, Rosmaninho-Salgado J, Cavadas C: Regulation of catecholamine release in human adrenal chromaffin cells by beta-adrenoceptors. Neurochem Int. 2012, 60 (4): 387-393. 10.1016/j.neuint.2011.12.018.PubMedCrossRef
82.
go back to reference Foucart S, de Champlain J, Nadeau R: In vivo interactions between prejunctional alpha 2- and beta 2-adrenoceptors at the level of the adrenal medulla. Can J Physiol Pharmacol. 1988, 66 (10): 1340-1343. 10.1139/y88-219.PubMedCrossRef Foucart S, de Champlain J, Nadeau R: In vivo interactions between prejunctional alpha 2- and beta 2-adrenoceptors at the level of the adrenal medulla. Can J Physiol Pharmacol. 1988, 66 (10): 1340-1343. 10.1139/y88-219.PubMedCrossRef
83.
go back to reference Cesetti T, Hernandez-Guijo JM, Baldelli P, Carabelli V, Carbone E: Opposite action of beta1- and beta2-adrenergic receptors on Ca(V)1 L-channel current in rat adrenal chromaffin cells. Int J Neurosci. 2003, 23 (1): 73-83. Cesetti T, Hernandez-Guijo JM, Baldelli P, Carabelli V, Carbone E: Opposite action of beta1- and beta2-adrenergic receptors on Ca(V)1 L-channel current in rat adrenal chromaffin cells. Int J Neurosci. 2003, 23 (1): 73-83.
84.
go back to reference Foucart S, Nadeau R, de Champlain J: Local modulation of adrenal catecholamines release by beta-2 adrenoceptors in the anaesthetized dog. N Schmied Arch Pharmacol. 1988, 337 (1): 29-34.CrossRef Foucart S, Nadeau R, de Champlain J: Local modulation of adrenal catecholamines release by beta-2 adrenoceptors in the anaesthetized dog. N Schmied Arch Pharmacol. 1988, 337 (1): 29-34.CrossRef
85.
go back to reference Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Umanskaya A, Xie W, Shiomi T, Zalk R, Lacampagne A, Marks AR: Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 2011, 14 (2): 196-207. 10.1016/j.cmet.2011.05.014.PubMedCentralPubMedCrossRef Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Umanskaya A, Xie W, Shiomi T, Zalk R, Lacampagne A, Marks AR: Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 2011, 14 (2): 196-207. 10.1016/j.cmet.2011.05.014.PubMedCentralPubMedCrossRef
86.
go back to reference Plant DR, Lynch GS: Excitation-contraction coupling and sarcoplasmic reticulum function in mechanically skinned fibres from fast skeletal muscles of aged mice. J Physiol. 2002, 543 (Pt 1): 169-176.PubMedCentralPubMedCrossRef Plant DR, Lynch GS: Excitation-contraction coupling and sarcoplasmic reticulum function in mechanically skinned fibres from fast skeletal muscles of aged mice. J Physiol. 2002, 543 (Pt 1): 169-176.PubMedCentralPubMedCrossRef
87.
go back to reference Lynch GS, Ryall JG: Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev. 2008, 88 (2): 729-767. 10.1152/physrev.00028.2007.PubMedCrossRef Lynch GS, Ryall JG: Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev. 2008, 88 (2): 729-767. 10.1152/physrev.00028.2007.PubMedCrossRef
88.
go back to reference Elfellah MS, Dalling R, Kantola IM, Reid JL: Beta-adrenoceptors and human skeletal muscle characterisation of receptor subtype and effect of age. Br J Clin Pharmacol. 1989, 27 (1): 31-38. 10.1111/j.1365-2125.1989.tb05332.x.PubMedCentralPubMedCrossRef Elfellah MS, Dalling R, Kantola IM, Reid JL: Beta-adrenoceptors and human skeletal muscle characterisation of receptor subtype and effect of age. Br J Clin Pharmacol. 1989, 27 (1): 31-38. 10.1111/j.1365-2125.1989.tb05332.x.PubMedCentralPubMedCrossRef
89.
go back to reference Kendall MJ, Woods KL, Wilkins MR, Worthington DJ: Responsiveness to beta-adrenergic receptor stimulation: the effects of age are cardioselective. Br J Clin Pharmacol. 1982, 14 (6): 821-826. 10.1111/j.1365-2125.1982.tb02043.x.PubMedCentralPubMedCrossRef Kendall MJ, Woods KL, Wilkins MR, Worthington DJ: Responsiveness to beta-adrenergic receptor stimulation: the effects of age are cardioselective. Br J Clin Pharmacol. 1982, 14 (6): 821-826. 10.1111/j.1365-2125.1982.tb02043.x.PubMedCentralPubMedCrossRef
90.
go back to reference Ford GA, Dachman WD, Blaschke TF, Hoffman BB: Effect of aging on beta 2-adrenergic receptor-stimulated flux of K+, PO4, FFA, and glycerol in human forearms. J Appl Physiol. 1995, 78 (1): 172-178.PubMed Ford GA, Dachman WD, Blaschke TF, Hoffman BB: Effect of aging on beta 2-adrenergic receptor-stimulated flux of K+, PO4, FFA, and glycerol in human forearms. J Appl Physiol. 1995, 78 (1): 172-178.PubMed
91.
go back to reference Ryall JG, Plant DR, Gregorevic P, Sillence MN, Lynch GS: Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol. 2004, 555 (Pt 1): 175-188.PubMedCentralPubMedCrossRef Ryall JG, Plant DR, Gregorevic P, Sillence MN, Lynch GS: Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol. 2004, 555 (Pt 1): 175-188.PubMedCentralPubMedCrossRef
92.
go back to reference Conte TC, Silva LH, Silva MT, Hirabara SM, Oliveira AC, Curi R, Moriscot AS, Aoki MS, Miyabara EH: The beta2-adrenoceptor agonist formoterol improves structural and functional regenerative capacity of skeletal muscles from aged rat at the early stages of postinjury. J Gerontol Biol Med Sci. 2012, 67 (5): 443-455.CrossRef Conte TC, Silva LH, Silva MT, Hirabara SM, Oliveira AC, Curi R, Moriscot AS, Aoki MS, Miyabara EH: The beta2-adrenoceptor agonist formoterol improves structural and functional regenerative capacity of skeletal muscles from aged rat at the early stages of postinjury. J Gerontol Biol Med Sci. 2012, 67 (5): 443-455.CrossRef
93.
go back to reference Santulli G, Ciccarelli M, Palumbo G, Campanile A, Galasso G, Ziaco B, Altobelli GG, Cimini V, Piscione F, D'Andrea LD: In vivo properties of the proangiogenic peptide QK. J Transl Med. 2009, 7: 41-10.1186/1479-5876-7-41.PubMedCentralPubMedCrossRef Santulli G, Ciccarelli M, Palumbo G, Campanile A, Galasso G, Ziaco B, Altobelli GG, Cimini V, Piscione F, D'Andrea LD: In vivo properties of the proangiogenic peptide QK. J Transl Med. 2009, 7: 41-10.1186/1479-5876-7-41.PubMedCentralPubMedCrossRef
94.
go back to reference Fusco A, Santulli G, Sorriento D, Cipolletta E, Garbi C, Dorn GW, Trimarco B, Feliciello A, Iaccarino G: Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell Signal. 2012, 24 (2): 468-475. 10.1016/j.cellsig.2011.09.026.PubMedCentralPubMedCrossRef Fusco A, Santulli G, Sorriento D, Cipolletta E, Garbi C, Dorn GW, Trimarco B, Feliciello A, Iaccarino G: Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell Signal. 2012, 24 (2): 468-475. 10.1016/j.cellsig.2011.09.026.PubMedCentralPubMedCrossRef
95.
go back to reference Robinson MM, Bell C, Peelor FF, Miller BF: beta-Adrenergic receptor blockade blunts postexercise skeletal muscle mitochondrial protein synthesis rates in humans. Am J Physiol Regul Integr Comp Physiol. 2011, 301 (2): R327-R334. 10.1152/ajpregu.00160.2011.PubMedCentralPubMedCrossRef Robinson MM, Bell C, Peelor FF, Miller BF: beta-Adrenergic receptor blockade blunts postexercise skeletal muscle mitochondrial protein synthesis rates in humans. Am J Physiol Regul Integr Comp Physiol. 2011, 301 (2): R327-R334. 10.1152/ajpregu.00160.2011.PubMedCentralPubMedCrossRef
96.
go back to reference Matarese A, Santulli G: Angiogenesis in Chronic Obstructive Pulmonary Disease: A Translational Appraisal. Transl Med @ UniSa. 2012, 3: 49-56. Matarese A, Santulli G: Angiogenesis in Chronic Obstructive Pulmonary Disease: A Translational Appraisal. Transl Med @ UniSa. 2012, 3: 49-56.
97.
go back to reference Ikeda T, Anisuzzaman AS, Yoshiki H, Sasaki M, Koshiji T, Uwada J, Nishimune A, Itoh H, Muramatsu I: Regional quantification of muscarinic acetylcholine receptors and beta-adrenoceptors in human airways. Br J Pharmacol. 2012, 166 (6): 1804-1814. 10.1111/j.1476-5381.2012.01881.x.PubMedCentralPubMedCrossRef Ikeda T, Anisuzzaman AS, Yoshiki H, Sasaki M, Koshiji T, Uwada J, Nishimune A, Itoh H, Muramatsu I: Regional quantification of muscarinic acetylcholine receptors and beta-adrenoceptors in human airways. Br J Pharmacol. 2012, 166 (6): 1804-1814. 10.1111/j.1476-5381.2012.01881.x.PubMedCentralPubMedCrossRef
98.
go back to reference Whitsett JA, Manton MA, Darovec-Beckerman C, Adams K: II. Beta-adrenergic receptors and catecholamine sensitive adenylate cyclase in the developing rat lung. Life Sci. 1981, 28 (4): 339-345. 10.1016/0024-3205(81)90077-1.PubMedCrossRef Whitsett JA, Manton MA, Darovec-Beckerman C, Adams K: II. Beta-adrenergic receptors and catecholamine sensitive adenylate cyclase in the developing rat lung. Life Sci. 1981, 28 (4): 339-345. 10.1016/0024-3205(81)90077-1.PubMedCrossRef
99.
go back to reference Scarpace PJ, Abrass IB: Decreased beta-adrenergic agonist affinity and adenylate cyclase activity in senescent rat lung. J Gerontol. 1983, 38 (2): 143-147. 10.1093/geronj/38.2.143.PubMedCrossRef Scarpace PJ, Abrass IB: Decreased beta-adrenergic agonist affinity and adenylate cyclase activity in senescent rat lung. J Gerontol. 1983, 38 (2): 143-147. 10.1093/geronj/38.2.143.PubMedCrossRef
100.
go back to reference Preuss JM, Rigby PJ, Goldie RG: The influence of animal age on beta-adrenoceptor density and function in tracheal airway smooth muscle. N Schmied Arch Pharmacol. 1999, 360 (2): 171-178. 10.1007/s002109900051.CrossRef Preuss JM, Rigby PJ, Goldie RG: The influence of animal age on beta-adrenoceptor density and function in tracheal airway smooth muscle. N Schmied Arch Pharmacol. 1999, 360 (2): 171-178. 10.1007/s002109900051.CrossRef
101.
go back to reference Roets E, Burvenich C: The influence of ageing on muscarinic receptors, beta-adrenoceptors and adenylate cyclase activity in the bovine lung. Vet Res Commun. 1995, 19 (3): 221-230. 10.1007/BF01839301.PubMedCrossRef Roets E, Burvenich C: The influence of ageing on muscarinic receptors, beta-adrenoceptors and adenylate cyclase activity in the bovine lung. Vet Res Commun. 1995, 19 (3): 221-230. 10.1007/BF01839301.PubMedCrossRef
102.
go back to reference Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE: Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest. 1995, 108 (2): 401-406. 10.1378/chest.108.2.401.PubMedCrossRef Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE: Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest. 1995, 108 (2): 401-406. 10.1378/chest.108.2.401.PubMedCrossRef
103.
go back to reference Ullah MI, Newman GB, Saunders KB: Influence of age on response to ipratropium and salbutamol in asthma. Thorax. 1981, 36 (7): 523-529. 10.1136/thx.36.7.523.PubMedCentralPubMedCrossRef Ullah MI, Newman GB, Saunders KB: Influence of age on response to ipratropium and salbutamol in asthma. Thorax. 1981, 36 (7): 523-529. 10.1136/thx.36.7.523.PubMedCentralPubMedCrossRef
104.
go back to reference Jackson WJ, Buccafusco JJ: Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacol Biochem Behav. 1991, 39 (1): 79-84. 10.1016/0091-3057(91)90400-V.PubMedCrossRef Jackson WJ, Buccafusco JJ: Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacol Biochem Behav. 1991, 39 (1): 79-84. 10.1016/0091-3057(91)90400-V.PubMedCrossRef
105.
go back to reference Viticchi C, Gentile S, Piantanelli L: Ageing and thymus-induced differential regulation of beta 1 and beta 2 adrenoceptors of mouse brain cortex. Arch Gerontol Geriatr. 1989, 8 (1): 13-20. 10.1016/0167-4943(89)90065-4.PubMedCrossRef Viticchi C, Gentile S, Piantanelli L: Ageing and thymus-induced differential regulation of beta 1 and beta 2 adrenoceptors of mouse brain cortex. Arch Gerontol Geriatr. 1989, 8 (1): 13-20. 10.1016/0167-4943(89)90065-4.PubMedCrossRef
106.
go back to reference Pittman RN, Minneman KP, Molinoff PB: Alterations in beta 1- and beta 2-adrenergic receptor density in the cerebellum of aging rats. J Neurochem. 1980, 35 (1): 273-275. 10.1111/j.1471-4159.1980.tb12517.x.PubMedCrossRef Pittman RN, Minneman KP, Molinoff PB: Alterations in beta 1- and beta 2-adrenergic receptor density in the cerebellum of aging rats. J Neurochem. 1980, 35 (1): 273-275. 10.1111/j.1471-4159.1980.tb12517.x.PubMedCrossRef
107.
go back to reference Bigham MH, Lidow MS: Adrenergic and serotonergic receptors in aged monkey neocortex. Neurobiology of aging. 1995, 16 (1): 91-104. 10.1016/0197-4580(95)80012-G.PubMedCrossRef Bigham MH, Lidow MS: Adrenergic and serotonergic receptors in aged monkey neocortex. Neurobiology of aging. 1995, 16 (1): 91-104. 10.1016/0197-4580(95)80012-G.PubMedCrossRef
108.
go back to reference Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR: Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. J Neurochem. 1989, 53 (6): 1772-1781. 10.1111/j.1471-4159.1989.tb09242.x.PubMedCrossRef Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR: Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. J Neurochem. 1989, 53 (6): 1772-1781. 10.1111/j.1471-4159.1989.tb09242.x.PubMedCrossRef
109.
go back to reference Griffin WS: Neuroinflammatory cytokine signaling and Alzheimer's disease. N Engl J Med. 2013, 368 (8): 770-771. 10.1056/NEJMcibr1214546.PubMedCrossRef Griffin WS: Neuroinflammatory cytokine signaling and Alzheimer's disease. N Engl J Med. 2013, 368 (8): 770-771. 10.1056/NEJMcibr1214546.PubMedCrossRef
110.
go back to reference Rabin LA, Pare N, Saykin AJ, Brown MJ, Wishart HA, Flashman LA, Santulli RB: Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease. Neuropsychol Dev Cognit Sect B. 2009, 16 (3): 357-376. 10.1080/13825580902825220.CrossRef Rabin LA, Pare N, Saykin AJ, Brown MJ, Wishart HA, Flashman LA, Santulli RB: Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease. Neuropsychol Dev Cognit Sect B. 2009, 16 (3): 357-376. 10.1080/13825580902825220.CrossRef
111.
go back to reference Russo-Neustadt A, Cotman CW: Adrenergic receptors in Alzheimer's disease brain: selective increases in the cerebella of aggressive patients. J Neurosci. 1997, 17 (14): 5573-5580.PubMed Russo-Neustadt A, Cotman CW: Adrenergic receptors in Alzheimer's disease brain: selective increases in the cerebella of aggressive patients. J Neurosci. 1997, 17 (14): 5573-5580.PubMed
112.
go back to reference Kalaria RN, Harik SI: Increased alpha 2- and beta 2-adrenergic receptors in cerebral microvessels in Alzheimer disease. Neurosci Lett. 1989, 106 (1–2): 233-238.PubMedCrossRef Kalaria RN, Harik SI: Increased alpha 2- and beta 2-adrenergic receptors in cerebral microvessels in Alzheimer disease. Neurosci Lett. 1989, 106 (1–2): 233-238.PubMedCrossRef
113.
go back to reference Dhondt TD, Beekman AT, Deeg DJ, Van Tilburg W: Iatrogenic depression in the elderly. Results from a community-based study in the Netherlands. Soc Psychiatr Psychiatr Epidemiol. 2002, 37 (8): 393-398. 10.1007/s00127-002-0573-4.CrossRef Dhondt TD, Beekman AT, Deeg DJ, Van Tilburg W: Iatrogenic depression in the elderly. Results from a community-based study in the Netherlands. Soc Psychiatr Psychiatr Epidemiol. 2002, 37 (8): 393-398. 10.1007/s00127-002-0573-4.CrossRef
114.
go back to reference Patten SB: Propranolol and depression: evidence from the antihypertensive trials. Can J Psychiatr. 1990, 35 (3): 257-259. Patten SB: Propranolol and depression: evidence from the antihypertensive trials. Can J Psychiatr. 1990, 35 (3): 257-259.
116.
go back to reference Luijendijk HJ, van den Berg JF, Hofman A, Tiemeier H, Stricker BH: beta-blockers and the risk of incident depression in the elderly. J Clin Psychopharmacol. 2011, 31 (1): 45-50. 10.1097/JCP.0b013e31820482c4.PubMedCrossRef Luijendijk HJ, van den Berg JF, Hofman A, Tiemeier H, Stricker BH: beta-blockers and the risk of incident depression in the elderly. J Clin Psychopharmacol. 2011, 31 (1): 45-50. 10.1097/JCP.0b013e31820482c4.PubMedCrossRef
117.
go back to reference Carstens ME, Engelbrecht AH, Russell VA, Aalbers C, Gagiano CA, Chalton DO, Taljaard JJ: Beta-adrenoceptors on lymphocytes of patients with major depressive disorder. Psychiatry research. 1987, 20 (3): 239-248. 10.1016/0165-1781(87)90084-9.PubMedCrossRef Carstens ME, Engelbrecht AH, Russell VA, Aalbers C, Gagiano CA, Chalton DO, Taljaard JJ: Beta-adrenoceptors on lymphocytes of patients with major depressive disorder. Psychiatry research. 1987, 20 (3): 239-248. 10.1016/0165-1781(87)90084-9.PubMedCrossRef
118.
go back to reference Lecrubier Y, Puech AJ, Jouvent R, Simon P, Widlocher D: A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study. Br J Psychiatr. 1980, 136: 354-358. 10.1192/bjp.136.4.354.CrossRef Lecrubier Y, Puech AJ, Jouvent R, Simon P, Widlocher D: A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study. Br J Psychiatr. 1980, 136: 354-358. 10.1192/bjp.136.4.354.CrossRef
120.
go back to reference Bulati M, Pellicano M, Vasto S, Colonna-Romano G: Understanding ageing: biomedical and bioengineering approaches, the immunologic view. Immun Ageing. 2008, 5: 9-10.1186/1742-4933-5-9.PubMedCentralPubMedCrossRef Bulati M, Pellicano M, Vasto S, Colonna-Romano G: Understanding ageing: biomedical and bioengineering approaches, the immunologic view. Immun Ageing. 2008, 5: 9-10.1186/1742-4933-5-9.PubMedCentralPubMedCrossRef
121.
go back to reference Crooks CV, Cross ML, Wall CR: Age-related differences in integrin expression in peripheral blood lymphocytes. Immun Ageing. 2010, 7: 5-10.1186/1742-4933-7-5.PubMedCentralPubMedCrossRef Crooks CV, Cross ML, Wall CR: Age-related differences in integrin expression in peripheral blood lymphocytes. Immun Ageing. 2010, 7: 5-10.1186/1742-4933-7-5.PubMedCentralPubMedCrossRef
122.
go back to reference Lee JB, Oelke M, Ramachandra L, Canaday DH, Schneck JP: Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors. Immun Ageing. 2011, 8: 6-10.1186/1742-4933-8-6.PubMedCentralPubMedCrossRef Lee JB, Oelke M, Ramachandra L, Canaday DH, Schneck JP: Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors. Immun Ageing. 2011, 8: 6-10.1186/1742-4933-8-6.PubMedCentralPubMedCrossRef
123.
go back to reference Cusi MG, Martorelli B, Di Genova G, Terrosi C, Campoccia G, Correale P: Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects. Immun Ageing. 2010, 7: 14-10.1186/1742-4933-7-14.PubMedCentralPubMedCrossRef Cusi MG, Martorelli B, Di Genova G, Terrosi C, Campoccia G, Correale P: Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects. Immun Ageing. 2010, 7: 14-10.1186/1742-4933-7-14.PubMedCentralPubMedCrossRef
124.
go back to reference Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G: Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing. 2008, 5: 6-10.1186/1742-4933-5-6.PubMedCentralPubMedCrossRef Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G: Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing. 2008, 5: 6-10.1186/1742-4933-5-6.PubMedCentralPubMedCrossRef
125.
go back to reference Schocken DD, Roth GS: Reduced beta-adrenergic receptor concentrations in ageing man. Nature. 1977, 267 (5614): 856-858. 10.1038/267856a0.PubMedCrossRef Schocken DD, Roth GS: Reduced beta-adrenergic receptor concentrations in ageing man. Nature. 1977, 267 (5614): 856-858. 10.1038/267856a0.PubMedCrossRef
126.
go back to reference Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJ: Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly. New Engl J Med. 1984, 310 (13): 815-819. 10.1056/NEJM198403293101303.PubMedCrossRef Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJ: Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly. New Engl J Med. 1984, 310 (13): 815-819. 10.1056/NEJM198403293101303.PubMedCrossRef
127.
go back to reference Xu B: The importance of beta-adrenergic receptors in immune regulation: a link between neuroendocrine and immune system. Medical hypotheses. 2001, 56 (3): 273-276. 10.1054/mehy.2000.1127.PubMedCrossRef Xu B: The importance of beta-adrenergic receptors in immune regulation: a link between neuroendocrine and immune system. Medical hypotheses. 2001, 56 (3): 273-276. 10.1054/mehy.2000.1127.PubMedCrossRef
128.
go back to reference Krall JF, Connelly M, Tuck ML: Evidence for reversibility of age-related decrease in human lymphocyte adenylate cyclase activity. Biochem Biophys Res Commun. 1981, 99 (3): 1028-1034. 10.1016/0006-291X(81)91264-X.PubMedCrossRef Krall JF, Connelly M, Tuck ML: Evidence for reversibility of age-related decrease in human lymphocyte adenylate cyclase activity. Biochem Biophys Res Commun. 1981, 99 (3): 1028-1034. 10.1016/0006-291X(81)91264-X.PubMedCrossRef
129.
go back to reference Mak JC, Nishikawa M, Barnes PJ: Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol. 1995, 268 (1 Pt 1): L41-L46.PubMed Mak JC, Nishikawa M, Barnes PJ: Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol. 1995, 268 (1 Pt 1): L41-L46.PubMed
130.
go back to reference Benschop RJ, Schedlowski M, Wienecke H, Jacobs R, Schmidt RE: Adrenergic control of natural killer cell circulation and adhesion. Brain Behav Immun. 1997, 11 (4): 321-332. 10.1006/brbi.1997.0499.PubMedCrossRef Benschop RJ, Schedlowski M, Wienecke H, Jacobs R, Schmidt RE: Adrenergic control of natural killer cell circulation and adhesion. Brain Behav Immun. 1997, 11 (4): 321-332. 10.1006/brbi.1997.0499.PubMedCrossRef
131.
go back to reference Manni M, Granstein RD, Maestroni G: beta2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response. Cytokine. 2011, 55 (3): 380-386. 10.1016/j.cyto.2011.05.013.PubMedCentralPubMedCrossRef Manni M, Granstein RD, Maestroni G: beta2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response. Cytokine. 2011, 55 (3): 380-386. 10.1016/j.cyto.2011.05.013.PubMedCentralPubMedCrossRef
132.
go back to reference Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlbock M, Roth E, Fugger R: Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock. 1999, 12 (6): 421-427. 10.1097/00024382-199912000-00002.PubMedCrossRef Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlbock M, Roth E, Fugger R: Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock. 1999, 12 (6): 421-427. 10.1097/00024382-199912000-00002.PubMedCrossRef
133.
go back to reference Mohamed-Ali V, Flower L, Sethi J, Hotamisligil G, Gray R, Humphries SE, York DA, Pinkney J: beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab. 2001, 86 (12): 5864-5869. 10.1210/jc.86.12.5864.PubMed Mohamed-Ali V, Flower L, Sethi J, Hotamisligil G, Gray R, Humphries SE, York DA, Pinkney J: beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab. 2001, 86 (12): 5864-5869. 10.1210/jc.86.12.5864.PubMed
134.
go back to reference Ogasawara J, Sanpei M, Rahman N, Sakurai T, Kizaki T, Hitomi Y, Ohno H, Izawa T: Beta-adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, beta-arrestin-2, and the ubiquitin-proteasome pathway. FASEB J. 2006, 20 (2): 350-352.PubMed Ogasawara J, Sanpei M, Rahman N, Sakurai T, Kizaki T, Hitomi Y, Ohno H, Izawa T: Beta-adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, beta-arrestin-2, and the ubiquitin-proteasome pathway. FASEB J. 2006, 20 (2): 350-352.PubMed
135.
go back to reference Teperino R, Amann S, Bayer M, McGee SL, Loipetzberger A, Connor T, Jaeger C, Kammerer B, Winter L, Wiche G: Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat. Cell. 2012, 151 (2): 414-426. 10.1016/j.cell.2012.09.021.PubMedCrossRef Teperino R, Amann S, Bayer M, McGee SL, Loipetzberger A, Connor T, Jaeger C, Kammerer B, Winter L, Wiche G: Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat. Cell. 2012, 151 (2): 414-426. 10.1016/j.cell.2012.09.021.PubMedCrossRef
136.
go back to reference Santulli G: Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology. 2012, 78 (11): 840-PubMedCrossRef Santulli G: Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology. 2012, 78 (11): 840-PubMedCrossRef
137.
go back to reference Noji T, Tashiro M, Yagi H, Nagashima K, Suzuki S, Kuroume T: Adaptive regulation of beta-adrenergic receptors in children with insulin dependent diabetes mellitus. Horm Metab Res. 1986, 18 (9): 604-606. 10.1055/s-2007-1012385.PubMedCrossRef Noji T, Tashiro M, Yagi H, Nagashima K, Suzuki S, Kuroume T: Adaptive regulation of beta-adrenergic receptors in children with insulin dependent diabetes mellitus. Horm Metab Res. 1986, 18 (9): 604-606. 10.1055/s-2007-1012385.PubMedCrossRef
138.
go back to reference Schwab KO, Bartels H, Martin C, Leichtenschlag EM: Decreased beta 2-adrenoceptor density and decreased isoproterenol induced c-AMP increase in juvenile type I diabetes mellitus: an additional cause of severe hypoglycaemia in childhood diabetes?. Eur J Pediatr. 1993, 152 (10): 797-801. 10.1007/BF02073373.PubMedCrossRef Schwab KO, Bartels H, Martin C, Leichtenschlag EM: Decreased beta 2-adrenoceptor density and decreased isoproterenol induced c-AMP increase in juvenile type I diabetes mellitus: an additional cause of severe hypoglycaemia in childhood diabetes?. Eur J Pediatr. 1993, 152 (10): 797-801. 10.1007/BF02073373.PubMedCrossRef
139.
go back to reference Loubatieres A, Mariani MM, Sorel G, Savi L: The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor. Diabetologia. 1971, 7 (3): 127-132. 10.1007/BF01212541.PubMedCrossRef Loubatieres A, Mariani MM, Sorel G, Savi L: The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor. Diabetologia. 1971, 7 (3): 127-132. 10.1007/BF01212541.PubMedCrossRef
140.
go back to reference Ahren B, Jarhult J, Lundquist I: Insulin secretion induced by glucose and by stimulation of beta 2 -adrenoceptors in the rat. Different sensitivity to somatostatin. Acta Physiol Scand. 1981, 112 (4): 421-426. 10.1111/j.1748-1716.1981.tb06839.x.PubMedCrossRef Ahren B, Jarhult J, Lundquist I: Insulin secretion induced by glucose and by stimulation of beta 2 -adrenoceptors in the rat. Different sensitivity to somatostatin. Acta Physiol Scand. 1981, 112 (4): 421-426. 10.1111/j.1748-1716.1981.tb06839.x.PubMedCrossRef
141.
go back to reference Panagiotidis G, Stenstrom A, Lundquist I: Influence of beta 2-adrenoceptor stimulation and glucose on islet monoamine oxidase activity and insulin secretory response in the mouse. Pancreas. 1993, 8 (3): 368-374. 10.1097/00006676-199305000-00014.PubMedCrossRef Panagiotidis G, Stenstrom A, Lundquist I: Influence of beta 2-adrenoceptor stimulation and glucose on islet monoamine oxidase activity and insulin secretory response in the mouse. Pancreas. 1993, 8 (3): 368-374. 10.1097/00006676-199305000-00014.PubMedCrossRef
142.
go back to reference Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, Arner P: Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Investig. 1997, 100 (12): 3005-3013. 10.1172/JCI119854.PubMedCentralPubMedCrossRef Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, Arner P: Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Investig. 1997, 100 (12): 3005-3013. 10.1172/JCI119854.PubMedCentralPubMedCrossRef
143.
go back to reference Thomsen M, Dahl M, Tybjaerg-Hansen A, Nordestgaard BG: beta2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals. J Clin Endocrinol Metab. 2012, 97 (6): E1074-E1079. 10.1210/jc.2011-3282.PubMedCrossRef Thomsen M, Dahl M, Tybjaerg-Hansen A, Nordestgaard BG: beta2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals. J Clin Endocrinol Metab. 2012, 97 (6): E1074-E1079. 10.1210/jc.2011-3282.PubMedCrossRef
144.
go back to reference Langin D, Portillo M, Dauzats M, Lafontan M: Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits. Endocrinology. 1992, 130 (1): 307-315. 10.1210/en.130.1.307.PubMed Langin D, Portillo M, Dauzats M, Lafontan M: Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits. Endocrinology. 1992, 130 (1): 307-315. 10.1210/en.130.1.307.PubMed
145.
go back to reference Gabaldon AM, McDonald RB, Horwitz BA: Effects of age, gender, and senescence on beta-adrenergic responses of isolated F344 rat brown adipocytes in vitro. Am J Physiol. 1998, 274 (4 Pt 1): E726-E736.PubMed Gabaldon AM, McDonald RB, Horwitz BA: Effects of age, gender, and senescence on beta-adrenergic responses of isolated F344 rat brown adipocytes in vitro. Am J Physiol. 1998, 274 (4 Pt 1): E726-E736.PubMed
146.
go back to reference Kerckhoffs DA, Blaak EE, Van Baak MA, Saris WH: Effect of aging on beta-adrenergically mediated thermogenesis in men. Am J Physiol. 1998, 274 (6 Pt 1): E1075-E1079.PubMed Kerckhoffs DA, Blaak EE, Van Baak MA, Saris WH: Effect of aging on beta-adrenergically mediated thermogenesis in men. Am J Physiol. 1998, 274 (6 Pt 1): E1075-E1079.PubMed
147.
go back to reference Lee YH, Petkova AP, Mottillo EP, Granneman JG: In vivo identification of bipotential adipocyte progenitors recruited by beta3-adrenoceptor activation and high-fat feeding. Cell metabolism. 2012, 15 (4): 480-491. 10.1016/j.cmet.2012.03.009.PubMedCentralPubMedCrossRef Lee YH, Petkova AP, Mottillo EP, Granneman JG: In vivo identification of bipotential adipocyte progenitors recruited by beta3-adrenoceptor activation and high-fat feeding. Cell metabolism. 2012, 15 (4): 480-491. 10.1016/j.cmet.2012.03.009.PubMedCentralPubMedCrossRef
148.
go back to reference Cinti S: The role of brown adipose tissue in human obesity. Nutr Metabol Cardiovasc Dis. 2006, 16 (8): 569-574. 10.1016/j.numecd.2006.07.009.CrossRef Cinti S: The role of brown adipose tissue in human obesity. Nutr Metabol Cardiovasc Dis. 2006, 16 (8): 569-574. 10.1016/j.numecd.2006.07.009.CrossRef
149.
go back to reference Gettys TW, Rohlfs EM, Prpic V, Daniel KW, Taylor IL, Collins S: Age-dependent changes in beta-adrenergic receptor subtypes and adenylyl cyclase activation in adipocytes from Fischer 344 rats. Endocrinology. 1995, 136 (5): 2022-2032. 10.1210/en.136.5.2022.PubMed Gettys TW, Rohlfs EM, Prpic V, Daniel KW, Taylor IL, Collins S: Age-dependent changes in beta-adrenergic receptor subtypes and adenylyl cyclase activation in adipocytes from Fischer 344 rats. Endocrinology. 1995, 136 (5): 2022-2032. 10.1210/en.136.5.2022.PubMed
150.
go back to reference Katz MS, Dax EM, Gregerman RI: Beta adrenergic regulation of rat liver glycogenolysis during aging. Exp Gerontol. 1993, 28 (4–5): 329-340.PubMedCrossRef Katz MS, Dax EM, Gregerman RI: Beta adrenergic regulation of rat liver glycogenolysis during aging. Exp Gerontol. 1993, 28 (4–5): 329-340.PubMedCrossRef
151.
go back to reference Graham SM, Herring PA, Arinze IJ: Age-associated alterations in hepatic beta-adrenergic receptor/adenylate cyclase complex. Am J Physiol. 1987, 253 (3 Pt 1): E277-E282.PubMed Graham SM, Herring PA, Arinze IJ: Age-associated alterations in hepatic beta-adrenergic receptor/adenylate cyclase complex. Am J Physiol. 1987, 253 (3 Pt 1): E277-E282.PubMed
152.
go back to reference Jin W: Age-related increase of beta1-adrenergic receptor gene expression in rat liver: a potential mechanism contributing to increased beta-adrenergic receptor density and responsiveness during aging. J Recept Signal Transduct Res. 2010, 30 (1): 24-30. 10.3109/10799890903358206.PubMedCrossRef Jin W: Age-related increase of beta1-adrenergic receptor gene expression in rat liver: a potential mechanism contributing to increased beta-adrenergic receptor density and responsiveness during aging. J Recept Signal Transduct Res. 2010, 30 (1): 24-30. 10.3109/10799890903358206.PubMedCrossRef
153.
go back to reference Van Ermen A, Van de Velde E, Vanscheeuwijck P, Fraeyman N: Influence of age on the beta 1- and beta 2-adrenergic receptors in rat liver. Mol Pharmacol. 1992, 42 (4): 649-655.PubMed Van Ermen A, Van de Velde E, Vanscheeuwijck P, Fraeyman N: Influence of age on the beta 1- and beta 2-adrenergic receptors in rat liver. Mol Pharmacol. 1992, 42 (4): 649-655.PubMed
154.
go back to reference Semsei I, Ma SY, Cutler RG: Tissue and age specific expression of the myc proto-oncogene family throughout the life span of the C57BL/6J mouse strain. Oncogene. 1989, 4 (4): 465-471.PubMed Semsei I, Ma SY, Cutler RG: Tissue and age specific expression of the myc proto-oncogene family throughout the life span of the C57BL/6J mouse strain. Oncogene. 1989, 4 (4): 465-471.PubMed
155.
go back to reference Schleifer LS, Black IB, Reid LM: Regulation of beta-adrenergic receptor expression in rat liver. J Cell Physiol. 1989, 140 (1): 52-58. 10.1002/jcp.1041400107.PubMedCrossRef Schleifer LS, Black IB, Reid LM: Regulation of beta-adrenergic receptor expression in rat liver. J Cell Physiol. 1989, 140 (1): 52-58. 10.1002/jcp.1041400107.PubMedCrossRef
156.
go back to reference Kassahun WT, Guenl B, Ungemach FR, Jonas S, Abraham G: Expression and functional coupling of liver beta2 - adrenoceptors in the human hepatocellular carcinoma. Pharmacology. 2012, 89 (5–6): 313-320.PubMedCrossRef Kassahun WT, Guenl B, Ungemach FR, Jonas S, Abraham G: Expression and functional coupling of liver beta2 - adrenoceptors in the human hepatocellular carcinoma. Pharmacology. 2012, 89 (5–6): 313-320.PubMedCrossRef
157.
go back to reference Santoro A, Simonelli M, Rodriguez-Lope C, Zucali P, Camacho LH, Granito A, Senzer N, Rimassa L, Abbadessa G, Schwartz B: A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis. Br J Cancer. 2013, 108 (1): 21-24. 10.1038/bjc.2012.556.PubMedCentralPubMedCrossRef Santoro A, Simonelli M, Rodriguez-Lope C, Zucali P, Camacho LH, Granito A, Senzer N, Rimassa L, Abbadessa G, Schwartz B: A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis. Br J Cancer. 2013, 108 (1): 21-24. 10.1038/bjc.2012.556.PubMedCentralPubMedCrossRef
158.
go back to reference Choudhury D, Levi M: Kidney aging–inevitable or preventable?. Nat Rev Nephrol. 2011, 7 (12): 706-717. 10.1038/nrneph.2011.104.PubMedCrossRef Choudhury D, Levi M: Kidney aging–inevitable or preventable?. Nat Rev Nephrol. 2011, 7 (12): 706-717. 10.1038/nrneph.2011.104.PubMedCrossRef
159.
go back to reference Perico N, Remuzzi G, Benigni A: Aging and the kidney. Curr Opin Nephrol Hypertens. 2011, 20 (3): 312-317. 10.1097/MNH.0b013e328344c327.PubMedCrossRef Perico N, Remuzzi G, Benigni A: Aging and the kidney. Curr Opin Nephrol Hypertens. 2011, 20 (3): 312-317. 10.1097/MNH.0b013e328344c327.PubMedCrossRef
160.
go back to reference Anderson S, Brenner BM: Effects of aging on the renal glomerulus. Am J Med. 1986, 80 (3): 435-442. 10.1016/0002-9343(86)90718-7.PubMedCrossRef Anderson S, Brenner BM: Effects of aging on the renal glomerulus. Am J Med. 1986, 80 (3): 435-442. 10.1016/0002-9343(86)90718-7.PubMedCrossRef
162.
go back to reference Goyal VK: Changes with age in the human kidney. Exp Gerontol. 1982, 17 (5): 321-331. 10.1016/0531-5565(82)90032-8.PubMedCrossRef Goyal VK: Changes with age in the human kidney. Exp Gerontol. 1982, 17 (5): 321-331. 10.1016/0531-5565(82)90032-8.PubMedCrossRef
163.
164.
go back to reference Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997, 390 (6655): 45-51. 10.1038/36285.PubMedCrossRef Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997, 390 (6655): 45-51. 10.1038/36285.PubMedCrossRef
165.
go back to reference Roush W: Fast-forward aging in a mutant mouse?. Science. 1997, 278 (5340): 1013-10.1126/science.278.5340.1013.PubMedCrossRef Roush W: Fast-forward aging in a mutant mouse?. Science. 1997, 278 (5340): 1013-10.1126/science.278.5340.1013.PubMedCrossRef
166.
go back to reference Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H: Suppression of aging in mice by the hormone Klotho. Science. 2005, 309 (5742): 1829-1833. 10.1126/science.1112766.PubMedCentralPubMedCrossRef Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H: Suppression of aging in mice by the hormone Klotho. Science. 2005, 309 (5742): 1829-1833. 10.1126/science.1112766.PubMedCentralPubMedCrossRef
167.
go back to reference Healy DP, Munzel PA, Insel PA: Localization of beta 1- and beta 2-adrenergic receptors in rat kidney by autoradiography. Circ Res. 1985, 57 (2): 278-284. 10.1161/01.RES.57.2.278.PubMedCrossRef Healy DP, Munzel PA, Insel PA: Localization of beta 1- and beta 2-adrenergic receptors in rat kidney by autoradiography. Circ Res. 1985, 57 (2): 278-284. 10.1161/01.RES.57.2.278.PubMedCrossRef
168.
go back to reference Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, Marumo T, Yatomi Y, Geller DS, Tanaka H: Epigenetic modulation of the renal beta-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nature medicine. 2011, 17 (5): 573-580. 10.1038/nm.2337.PubMedCrossRef Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, Marumo T, Yatomi Y, Geller DS, Tanaka H: Epigenetic modulation of the renal beta-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nature medicine. 2011, 17 (5): 573-580. 10.1038/nm.2337.PubMedCrossRef
169.
go back to reference Uchida S, Chiga M, Sohara E, Rai T, Sasaki S: Does a beta2-adrenergic receptor-WNK4-Na-Cl co-transporter signal cascade exist in the in vivo kidney?. Nature medicine. 2012, 18 (9): 1324-1325. 10.1038/nm.2809. author reply 1325–1327PubMedCrossRef Uchida S, Chiga M, Sohara E, Rai T, Sasaki S: Does a beta2-adrenergic receptor-WNK4-Na-Cl co-transporter signal cascade exist in the in vivo kidney?. Nature medicine. 2012, 18 (9): 1324-1325. 10.1038/nm.2809. author reply 1325–1327PubMedCrossRef
170.
go back to reference Milavec-Krizman M, Evenou JP, Wagner H, Berthold R, Stoll AP: Characterization of beta-adrenoceptor subtypes in rat kidney with new highly selective beta 1 blockers and their role in renin release. Biochem Pharmacol. 1985, 34 (22): 3951-3957. 10.1016/0006-2952(85)90371-5.PubMedCrossRef Milavec-Krizman M, Evenou JP, Wagner H, Berthold R, Stoll AP: Characterization of beta-adrenoceptor subtypes in rat kidney with new highly selective beta 1 blockers and their role in renin release. Biochem Pharmacol. 1985, 34 (22): 3951-3957. 10.1016/0006-2952(85)90371-5.PubMedCrossRef
171.
go back to reference Galbusera M, Garattini S, Remuzzi G, Mennini T: Catecholamine receptor binding in rat kidney: effect of aging. Kidney Int. 1988, 33 (6): 1073-1077. 10.1038/ki.1988.113.PubMedCrossRef Galbusera M, Garattini S, Remuzzi G, Mennini T: Catecholamine receptor binding in rat kidney: effect of aging. Kidney Int. 1988, 33 (6): 1073-1077. 10.1038/ki.1988.113.PubMedCrossRef
172.
go back to reference Fraeyman N, Van de Velde E, Van Ermen A, Bazan A, Vanderheyden P, Van Emmelo J, Vandekerckhove J: Effect of maturation and aging on beta-adrenergic signal transduction in rat kidney and liver. Biochem Pharmacol. 2000, 60 (12): 1787-1795. 10.1016/S0006-2952(00)00493-7.PubMedCrossRef Fraeyman N, Van de Velde E, Van Ermen A, Bazan A, Vanderheyden P, Van Emmelo J, Vandekerckhove J: Effect of maturation and aging on beta-adrenergic signal transduction in rat kidney and liver. Biochem Pharmacol. 2000, 60 (12): 1787-1795. 10.1016/S0006-2952(00)00493-7.PubMedCrossRef
174.
go back to reference Harada S, Rodan GA: Control of osteoblast function and regulation of bone mass. Nature. 2003, 423 (6937): 349-355. 10.1038/nature01660.PubMedCrossRef Harada S, Rodan GA: Control of osteoblast function and regulation of bone mass. Nature. 2003, 423 (6937): 349-355. 10.1038/nature01660.PubMedCrossRef
175.
go back to reference Hanyu R, Wehbi VL, Hayata T, Moriya S, Feinstein TN, Ezura Y, Nagao M, Saita Y, Hemmi H, Notomi T: Anabolic action of parathyroid hormone regulated by the beta2-adrenergic receptor. Proc Natl Acad Sci U S A. 2012, 109 (19): 7433-7438. 10.1073/pnas.1109036109.PubMedCentralPubMedCrossRef Hanyu R, Wehbi VL, Hayata T, Moriya S, Feinstein TN, Ezura Y, Nagao M, Saita Y, Hemmi H, Notomi T: Anabolic action of parathyroid hormone regulated by the beta2-adrenergic receptor. Proc Natl Acad Sci U S A. 2012, 109 (19): 7433-7438. 10.1073/pnas.1109036109.PubMedCentralPubMedCrossRef
176.
go back to reference Bonnet N, Benhamou CL, Brunet-Imbault B, Arlettaz A, Horcajada MN, Richard O, Vico L, Collomp K, Courteix D: Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone. 2005, 37 (5): 622-633. 10.1016/j.bone.2005.07.012.PubMedCrossRef Bonnet N, Benhamou CL, Brunet-Imbault B, Arlettaz A, Horcajada MN, Richard O, Vico L, Collomp K, Courteix D: Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone. 2005, 37 (5): 622-633. 10.1016/j.bone.2005.07.012.PubMedCrossRef
177.
go back to reference Pierroz DD, Bonnet N, Bianchi EN, Bouxsein ML, Baldock PA, Rizzoli R, Ferrari SL: Deletion of beta-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation. J Bone Miner Res. 2012, 27 (6): 1252-1262. 10.1002/jbmr.1594.PubMedCrossRef Pierroz DD, Bonnet N, Bianchi EN, Bouxsein ML, Baldock PA, Rizzoli R, Ferrari SL: Deletion of beta-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation. J Bone Miner Res. 2012, 27 (6): 1252-1262. 10.1002/jbmr.1594.PubMedCrossRef
178.
go back to reference DiGirolamo DJ, Clemens TL, Kousteni S: The skeleton as an endocrine organ. Nat Rev Rheumatol. 2012, 8 (11): 674-683. 10.1038/nrrheum.2012.157.PubMedCrossRef DiGirolamo DJ, Clemens TL, Kousteni S: The skeleton as an endocrine organ. Nat Rev Rheumatol. 2012, 8 (11): 674-683. 10.1038/nrrheum.2012.157.PubMedCrossRef
179.
go back to reference Weiss R: Review: Beta blockers differ in their efficacy for preventing major cardiovascular events in younger and older patients. Evid Base Med. 2006, 11 (6): 168-10.1136/ebm.11.6.168.CrossRef Weiss R: Review: Beta blockers differ in their efficacy for preventing major cardiovascular events in younger and older patients. Evid Base Med. 2006, 11 (6): 168-10.1136/ebm.11.6.168.CrossRef
180.
go back to reference Khan N, McAlister FA: Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. Can Med Assoc J. 2006, 174 (12): 1737-1742. 10.1503/cmaj.060110.CrossRef Khan N, McAlister FA: Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. Can Med Assoc J. 2006, 174 (12): 1737-1742. 10.1503/cmaj.060110.CrossRef
181.
go back to reference Khan N, McAlister FA: Beta blockers for the treatment of primary hypertension. Lancet. 2006, 367 (9506): 208-10.1016/S0140-6736(06)68027-6. author reply 210PubMedCrossRef Khan N, McAlister FA: Beta blockers for the treatment of primary hypertension. Lancet. 2006, 367 (9506): 208-10.1016/S0140-6736(06)68027-6. author reply 210PubMedCrossRef
Metadata
Title
Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes
Authors
Gaetano Santulli
Guido Iaccarino
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2013
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/1742-4933-10-10

Other articles of this Issue 1/2013

Immunity & Ageing 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.